AML1/RUNX1 fusion gene and t(5;21)(q13;q22) in a case of chronic myelomonocytic leukemia with progressive thrombocytopenia and monocytosis [3]

Cancer Genetics and Cytogenetics

Volumn 152, Issue 2, 2004, Pages 172-174

  Liu, Shihe ^a   Li, Chengwen ^a   Bo, Lijin ^a   Dai, Yun ^a   Xiao, Zhijian ^b   Wang, Jianxiang ^c  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b NONE   (China)

^c The   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; IMMUNOGLOBULIN; TOPOTECAN; TRANSCRIPTION FACTOR RUNX1;

ADULT; ANAMNESIS; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION 13; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 5; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; CYTOCHEMISTRY; ECCHYMOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE REARRANGEMENT; HEPATOSPLENOMEGALY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KARYOTYPE; LETTER; LEUKOCYTE COUNT; LYMPHADENOPATHY; MONOCYTOSIS; PETECHIA; PHENOTYPE; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 5; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DISEASE PROGRESSION; DNA-BINDING PROTEINS; FEMALE; HUMANS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MIDDLE AGED; MONOCYTES; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEINS; THROMBOCYTOPENIA; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 3242729662     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2003.11.002     Document Type: Letter

References (10)

1. Mitelman F., Nilsson P.G., Brandt L., Alimena G., Gastqaldi R., Dallapiccola B. Chromosome pattern, occupation, and clinical features in patients with acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 4:1981;197-214
2. Gogineni S.K., da Costa M., Verma R.S. A new translocation, t(5;21) (q13;q22) in acute myelogenous leukemia. Cancer Genet Cytogenet. 88:1996;167-169
3. Roulston D., Espinosa R. III, Nucifora G., Larson R.A., Le Beau M.M., Rowley J.D. CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapy. Blood. 92:1998;2879-2885
4. Mitelman F. An international system for human cytogenetic nomenclature. 1995;S. Karger, Basel
5. Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink H.K., Vardiman J., Lister T.A., Bloomfield C.D. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997. J Clin Oncol. 17:1999;3835-3849
6. Groupe Français de Cytogénétique Hematologique. Chronic myelomonocytic leukemia: single entity or heterogeneous disorder? A prospective multicenter study of 100 patients. Cancer Genet Cytogenet. 55:1991;57-65
7. Slovak M.L., Bedell V., Popplewell L., Arber D.A., Schoch C., Slater R. 21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop. Genes Chromosomes Cancer. 33:2002;379-394
8. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 84:1996;321-330
9. Wang Q., Stacy T., Binder M., Marin-Padilla M., Sharpes A.H., Speck N.A. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous systems and blocks definitive hematopoiesis. Proc Natl Acad Sci USA. 93:1996;3444-3449
10. Tenen D.G., Hromas R., Licht J.D., Zhang D.E. Transcription factors, normal myeloid development, and leukemia. Blood. 90:1997;489-519